Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods with acceptable restrictions
Remarks:
Basic data given (no details on test substance given, only limited data on results available)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1994
Report date:
1994

Materials and methods

Principles of method if other than guideline:
Acute toxicity was tested in male mice after receiving a single dose of the test item. The animals were observed over a time period of 6 days.
GLP compliance:
not specified
Test type:
other: no guideline followed

Test material

Constituent 1
Reference substance name:
Fatty acids, C16-18, esters with diethylene glycol
EC Number:
285-550-1
EC Name:
Fatty acids, C16-18, esters with diethylene glycol
Cas Number:
85116-97-8
Molecular formula:
Not applicable as UVCB
IUPAC Name:
Fatty acids, C16-18, esters with diethylene glycol

Test animals

Species:
mouse
Strain:
other: NMRI EOPS
Sex:
male

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
not specified
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 6 days

Results and discussion

Effect levels
Sex:
male
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality was observed until the end of the observation eriod.
Clinical signs:
other: No signs indicative for anomalies observed until the end of the observation period.
Body weight:
other body weight observations
Remarks:
body weight appeared normal.

Applicant's summary and conclusion

Interpretation of results:
other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008